Structured treatment interruptions for the management of HIV infection.
about
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adultsStructured treatment interruptions (STI) in chronic suppressed HIV infection in adultsRandomized, controlled trial of therapy interruption in chronic HIV-1 infectionCerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionHIV therapeutic vaccines: moving towards a functional cureDrug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohortsCombination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy.Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques.Can structured treatment interruptions (STIs) be used as a strategy to decrease total drug requirements and toxicity in HIV infection?Generation of HIV latency in humanized BLT mice.APC-targeted immunization for the treatment of HIV-1.Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection.Interrupting highly active antiretroviral therapy in patients with HIV.Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infectionPredictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohortART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resumEpisodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial.Modeling HIV persistence, the latent reservoir, and viral blips.Antiretroviral therapy in children: recent advances.Current views on interferon therapy for HIV.Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption.Correlates of antiretroviral treatment breaks.
P2860
Q24245541-0DF34C72-EC58-4CAB-91C6-6B87C8992405Q24245709-3709A065-3EFE-4B83-834E-BE1DB5F01AAEQ24809608-F1ED1752-2E77-46B1-B51A-3D23286F5A28Q24810504-CA5BCFBC-B12B-4700-AEE4-3CFC27EE1F89Q27002180-5DAEC3C4-0C78-4993-9C77-FFC6FF48CCDBQ28477883-D23487DC-1F9A-497C-B3C7-01EDB7AB9AD8Q34338893-6578359B-DE34-4B1B-B6AF-E19575C2D8C9Q34348075-DDE9D436-43C9-40E6-A389-E46874CC7FECQ34716901-96CC6A92-8857-4C63-8ADC-A54A76D9D9F5Q35207318-1A9252F8-53C3-4ACB-BFCD-0109AEC34D08Q35666126-0C0BBA1A-34C2-4551-BDC4-59E2EADA256DQ35851829-C4938FDB-A826-4FE2-B935-A733897E2F95Q35917465-0A8E1617-D254-49B5-8CA0-9860CD74A0E4Q36026242-9682147B-D94B-413C-B566-4F42140BC7BCQ36066209-74532480-392A-4093-917D-017EFBDB6C0AQ36099376-05901C4E-6C24-4377-8A31-0715054B2101Q36171488-A5581931-E571-4D2D-8DB0-44841EF4915CQ36618563-674D155B-50F2-408B-9821-009573B380E2Q37304799-2FFEEC0F-E10F-4E36-A778-5ABE00496D1CQ37357997-0CA643D2-6C89-44C7-9C3E-BF77608C2769Q37365718-79A8AA58-FB9D-4FA4-8D3B-DDEB301B9C3AQ38062862-FDF5B7FE-D3D4-471B-BFFC-D2A2FD14EAA6Q38860634-050C074A-0054-4EBA-B77A-E72F3F82B6B6Q44655783-E892F8BF-6696-4526-8E69-E14CF83B5B9EQ45413163-99256108-85F9-475A-820D-5C570AE082CAQ48563096-F1EA526E-56DE-405C-8A2E-DC116490B6C7
P2860
Structured treatment interruptions for the management of HIV infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Structured treatment interruptions for the management of HIV infection.
@ast
Structured treatment interruptions for the management of HIV infection.
@en
Structured treatment interruptions for the management of HIV infection.
@nl
type
label
Structured treatment interruptions for the management of HIV infection.
@ast
Structured treatment interruptions for the management of HIV infection.
@en
Structured treatment interruptions for the management of HIV infection.
@nl
prefLabel
Structured treatment interruptions for the management of HIV infection.
@ast
Structured treatment interruptions for the management of HIV infection.
@en
Structured treatment interruptions for the management of HIV infection.
@nl
P356
P1476
Structured treatment interruptions for the management of HIV infection.
@en
P2093
P304
P356
10.1001/JAMA.286.23.2981
P407
P577
2001-12-01T00:00:00Z